Skip to main content
. 2018 Jun 21;2018:9831079. doi: 10.1155/2018/9831079

Table 4.

Clinical characteristics of patients with clinical worsening, poor functional outcomes, and severe disability.

Clinical worsening Poor function outcomes, mRS ≥ 4 Severe disability, BI ≤ 30
Yes No p Yes No p Yes No p
N 13 25 30 8 21 17
Female (%) 8 (61.5) 11 (44.0) 0.30 16 (53.3) 3 (37.5) 0.69 13 (61.9) 6 (35.3) 0.10
Age (years) 71.6 (17.7) 68.4 (13.4) 0.53 71.1 (14.5) 63.2 (15.8) 0.90 70.8 (16.1) 67.8 (13.5) 0.54
NIHSS 16.9 (8.7) 16.6 (7.4) 0.91 17.7 (7.9) 12.8 (7.3) 0.11 19.0 (7.2) 13.9 (8.0) 0.04
HTN (%) 12 (92.3) 15 (60.0) 0.03 23 (76.7) 4 (50.0) 0.19 17 (80.9) 10 (58.8) 0.13
DM (%) 7 (53.8) 5 (20.0) 0.03 12 (40.0) 0 (0.0) 0.03 9 (42.8) 3 (17.6) 0.09
CAD (%) 4 (30.7) 5 (32.0) 0.69 7 (23.3) 2 (25.0) 1.0 5 (23.8) 4 (23.5) 0.98
CKD (%) 5 (38.4) 2 (8.0) 0.20 6 (20.0) 1 (12.5) 1.0 5 (23.8) 2 (11.7) 0.33
Smoker (%) 1 (7.69) 8 (32.0) 0.12 7 (23.3) 2 (25.0) 1.0 5 (23.8) 4 (23.5) 0.98
Hemoglobin (g/dl) 12.7 (3.17) 14.5 (2.3) 0.05 13.7 (3.0) 14.2 (1.3) 0.66 13.0 (3.2) 14.9 (1.5) 0.02
Platelets (103/μl) 212 (108) 215 (45) 0.98 219 (77) 197 (31) 0.45 218 (92) 209 (30) 0.69
WBC (103/mm3) 12.0 (6.6) 10.5 (3.7) 0.37 10.2 (3.2) 11.3 (5.3) 0.60 11.6 (5.6) 10.0 (2.9) 0.37
BUN (mg/dl) 23.2 (14.7) 21.1 (11.2) 0.68 27.0 (19.0) 19.5 (7.2) 0.15 26.2 (3.4) 18.0 (3.4) 0.09
Creatinine (mg/dl) 2.41 (2.85) 1.05 (0.41) 0.02 1.66 (1.96) 0.94 (0.17) 0.31 1.92 (2.3) 1.03 (0.36) 0.12
CRP (mg/dl) 10.9 (10.1) 2.8 (4.3) 0.02 6.0 (7.9) 1.7 (1.1) 0.30 8.48 (9.0) 1.66 (1.0) 0.03
IV-t-PA (%) 1 (7.69) 12 (48.0) 0.01 8 (26.7) 5 (62.5) 0.09 1 (4.7) 12 (70.6) 0.001
TSPO 0.58 (0.53) 0.30 (0.57) 0.02 0.53 (0.61) 0.08 (0.33) 0.003 0.58 (0.47) 0.19 (0.61) 0.03

Values are mean (standard deviation) or n (%), as appropriate. TSPO values (ng/ml) are median (interquartile range). NIHSS, National Institutes of Health Stroke Scale; HTN, hypertension; DM, diabetes mellitus; CAD, coronary artery disease; CKD, chronic kidney disease; WBC, white blood count; CRP, highly sensitive C-reactive protein; IV-t-PA, intravenous tissue plasminogen activator; TSPO, translocator protein.